The H520 cells carry gene mutations, including TP53 (translated p53) and CDKN2A (translated p14 ARF and p16 INK4A), which plays an important roles as RUNX3 target genes and co-activators of tumor suppression. This evidence concerns the gene CDKN2A and neoplasm.